Abstract
The US COVID-19 public health emergency and related legislation facilitated a rapid acceleration of telehealth/telemedicine services by removing restrictions on patient and clinician location, waiving interstate licensure requirements, and providing for professional fee reimbursement on-par with in-person services. Telehealth claims have stabilized at 38 times higher than prepandemic levels as of July 2021.1 In a recent national survey of hepatology practitioners, 98% were using telehealth to conduct appointments, 88% viewed telehealth favorably, and 35% believed that most patients preferred telehealth over in-person visits.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
